The ARMOR Study: A Phase 3, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)

  • Hodge, Alex (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: SMHS HREC RGS0000003915
NMA SSA Reference Number: SSA/64813/MonH-2020-219626(v1)
Monash Health Reference: RES-20-0000-462X
Effective start/end date23/07/2029/07/25


  • clinical trial
  • steatohepatitis
  • treatment safety
  • treatment efficacy